Literature DB >> 22260403

Induction of gut IgA production through T cell-dependent and T cell-independent pathways.

Mats Bemark1, Preben Boysen, Nils Y Lycke.   

Abstract

The gut immune system protects against mucosal pathogens, maintains a mutualistic relationship with the microbiota, and establishes tolerance against food antigens. This requires a balance between immune effector responses and induction of tolerance. Disturbances of this strictly regulated balance can lead to infections or the development inflammatory diseases and allergies. Production of secretory IgA is a unique effector function at mucosal surfaces, and basal mechanisms regulating IgA production have been the focus of much recent research. These investigations have aimed at understanding how long-term IgA-mediated mucosal immunity can best be achieved by oral or sublingual vaccination, or at analyzing the relationship between IgA production, the composition of the gut microbiota, and protection from allergies and autoimmunity. This research has lead to a better understanding of the IgA system; but at the same time seemingly conflicting data have been generated. Here, we discuss how gut IgA production is controlled, with special focus on how differences between T cell-dependent and T cell-independent IgA production may explain some of these discrepancies.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260403     DOI: 10.1111/j.1749-6632.2011.06378.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  43 in total

Review 1.  Regulation of intestinal IgA responses.

Authors:  Na Xiong; Shaomin Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-03       Impact factor: 9.261

2.  Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production.

Authors:  H Takaki; S Kure; H Oshiumi; Y Sakoda; T Suzuki; A Ainai; H Hasegawa; M Matsumoto; T Seya
Journal:  Mucosal Immunol       Date:  2017-06-15       Impact factor: 7.313

Review 3.  The regulation of gut mucosal IgA B-cell responses: recent developments.

Authors:  N Y Lycke; M Bemark
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

Review 4.  Evolution of B cell immunity.

Authors:  David Parra; Fumio Takizawa; J Oriol Sunyer
Journal:  Annu Rev Anim Biosci       Date:  2013-01       Impact factor: 8.923

5.  MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health.

Authors:  Jason L Kubinak; Charisse Petersen; W Zac Stephens; Ray Soto; Erin Bake; Ryan M O'Connell; June L Round
Journal:  Cell Host Microbe       Date:  2015-01-22       Impact factor: 21.023

6.  αvβ8 integrin-expression by BATF3-dependent dendritic cells facilitates early IgA responses to Rotavirus.

Authors:  J Nakawesi; S This; J Hütter; M Boucard-Jourdin; V Barateau; K Getachew Muleta; L J Gooday; K Fog Thomsen; A Garcias López; I Ulmert; D Poncet; B Malissen; H Greenberg; O Thaunat; T Defrance; H Paidassi; K Lahl
Journal:  Mucosal Immunol       Date:  2020-03-11       Impact factor: 7.313

7.  Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.

Authors:  Xiaohong Xu; Jing Qian; Lingsong Qin; Jindou Li; Cong Xue; Jiaxin Ding; Weiqi Wang; Wei Ding; Renfu Yin; Ningyi Jin; Zhuang Ding
Journal:  Virol Sin       Date:  2020-04-09       Impact factor: 4.327

8.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

Review 9.  Role of the gut microbiota in the development and function of lymphoid cells.

Authors:  Nobuhiko Kamada; Gabriel Núñez
Journal:  J Immunol       Date:  2013-02-15       Impact factor: 5.422

10.  IgA response in preterm neonates shows little evidence of antigen-driven selection.

Authors:  Tobias Rogosch; Sebastian Kerzel; Katharina Hoss; Gabriele Hoersch; Cosima Zemlin; Matthias Heckmann; Claudia Berek; Harry W Schroeder; Rolf F Maier; Michael Zemlin
Journal:  J Immunol       Date:  2012-10-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.